{
    "info": {
        "nct_id": "NCT03863704",
        "official_title": "Transcutaneous Vagal Nerve Stimulation to Treat Pediatric Inflammatory Bowel Disease",
        "inclusion_criteria": "1. Age 10-21 years\n2. IBD diagnosis for at least 3 months, confirmed by clinical, biochemical, and endoscopic evaluations\n3. Elevated Fecal calprotectin ≥ 200 ug/g within the past 4 weeks prior to enrollment\n4. Evidence of active inflammatory disease despite treatment with at least one conventional therapy\n5. If on corticosteroids, the dose must be stable and ≤ 10mg/day (prednisone or equivalent) for at least 14 days before entry into study\n6. If on 5-Aminosalicylate, dose must be stable with following parameters:\n\n   * 28 days on oral medication\n   * Prior to baseline calprotectin, 28 days on rectal medication or 2 weeks off rectal medication\n7. If on background immunosuppressive treatment the dose must be stable with the following parameters:\n\n   * 56 days (8 weeks) for Immunomodulators (methotrexate, 6-MP, Azathioprine)\n   * 112 days (16 weeks) for Infliximab, Adalimumab, Vedolizumab, Ustekinumab, other biologic\n8. Able and willing to give written informed consent and comply with the requirements of the study protocol.\nHealthy volunteers allowed\nMust have minimum age of 10 Years\nMust have maximum age of 21 Years",
        "exclusion_criteria": "1. Expectation to increase corticosteroids and/or immunosuppressive treatment\n2. Presence of bowel stricture with prestenotic dilatation\n3. Presence of intra-abdominal or perirectal abscess\n4. Pediatric UC activity Index (PUCAI) score ≥ 65 (severe)\n5. weighted Pediatric Crohn Disease Activity Index (wPCDAI) score > 57.5 (severe)\n6. Active treatment with antibiotics\n7. Presence of active intestinal infection or documented infection by stool PCR or culture analysis in the previous 6 weeks\n8. Continuous treatment with an anti-cholinergic medication, including over the counter medications\n9. Implantable electronic devices such as pacemakers, defibrillators, hearing aids, cochlear implants or deep brain stimulators.\n10. Current tobacco or nicotine user (to limit potential confounding effects of exposure to nicotine)\n11. Bowel resection surgery within past 90 days prior to study enrollment and on no conventional IBD therapy, or planned surgery within the course of the study\n12. Any planned surgical procedure requiring general anesthesia within the course of the study\n13. Participation in any other Investigational drug and/or treatment currently or planned during the length of the study\n14. Any condition which, in the opinion of the investigator, would jeopardize the subject's safety following exposure to a study intervention\n15. Pregnancy or Lactation\n16. Comorbid disease with high likelihood of requiring corticosteroid use\n17. Inability to comply with study and follow-up procedures\n18. Non-English speaking\n19. Known cardiac condition causing or with potential to cause arrhythmia",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Prior to baseline calprotectin, 28 days on rectal medication or 2 weeks off rectal medication",
            "criterions": [
                {
                    "exact_snippets": "Prior to baseline calprotectin, 28 days on rectal medication",
                    "criterion": "rectal medication use",
                    "requirements": [
                        {
                            "requirement_type": "duration_on_medication",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "2 weeks off rectal medication",
                    "criterion": "rectal medication use",
                    "requirements": [
                        {
                            "requirement_type": "duration_off_medication",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* 28 days on oral medication",
            "criterions": [
                {
                    "exact_snippets": "28 days on oral medication",
                    "criterion": "oral medication",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": "=",
                                "value": 28,
                                "unit": "days"
                            }
                        },
                        {
                            "requirement_type": "route of administration",
                            "expected_value": "oral"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Elevated Fecal calprotectin ≥ 200 ug/g within the past 4 weeks prior to enrollment",
            "criterions": [
                {
                    "exact_snippets": "Elevated Fecal calprotectin ≥ 200 ug/g within the past 4 weeks prior to enrollment",
                    "criterion": "Fecal calprotectin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 200,
                                "unit": "ug/g"
                            }
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": "within the past 4 weeks prior to enrollment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Age 10-21 years",
            "criterions": [
                {
                    "exact_snippets": "Age 10-21 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "range",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 10,
                                        "unit": "years"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 21,
                                        "unit": "years"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. If on 5-Aminosalicylate, dose must be stable with following parameters:",
            "criterions": [
                {
                    "exact_snippets": "If on 5-Aminosalicylate, dose must be stable",
                    "criterion": "5-Aminosalicylate dose",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. If on background immunosuppressive treatment the dose must be stable with the following parameters:",
            "criterions": [
                {
                    "exact_snippets": "on background immunosuppressive treatment",
                    "criterion": "background immunosuppressive treatment",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "the dose must be stable",
                    "criterion": "immunosuppressive treatment dose",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. If on corticosteroids, the dose must be stable and ≤ 10mg/day (prednisone or equivalent) for at least 14 days before entry into study",
            "criterions": [
                {
                    "exact_snippets": "If on corticosteroids",
                    "criterion": "corticosteroid use",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "the dose must be stable",
                    "criterion": "corticosteroid dose",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "≤ 10mg/day (prednisone or equivalent)",
                    "criterion": "corticosteroid dose",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 10,
                                "unit": "mg/day (prednisone or equivalent)"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "for at least 14 days before entry into study",
                    "criterion": "corticosteroid dose",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 14,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 10 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 10 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Able and willing to give written informed consent and comply with the requirements of the study protocol.",
            "criterions": [
                {
                    "exact_snippets": "Able ... to give written informed consent",
                    "criterion": "ability to give written informed consent",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willing to give written informed consent",
                    "criterion": "willingness to give written informed consent",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "comply with the requirements of the study protocol",
                    "criterion": "ability and willingness to comply with study protocol",
                    "requirements": [
                        {
                            "requirement_type": "ability and willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 21 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 21 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 21,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* 56 days (8 weeks) for Immunomodulators (methotrexate, 6-MP, Azathioprine)",
            "criterions": [
                {
                    "exact_snippets": "56 days (8 weeks) for Immunomodulators (methotrexate, 6-MP, Azathioprine)",
                    "criterion": "immunomodulator use (methotrexate, 6-MP, Azathioprine)",
                    "requirements": [
                        {
                            "requirement_type": "washout period",
                            "expected_value": {
                                "operator": ">=",
                                "value": 56,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* 112 days (16 weeks) for Infliximab, Adalimumab, Vedolizumab, Ustekinumab, other biologic",
            "criterions": [
                {
                    "exact_snippets": "112 days (16 weeks) for Infliximab, Adalimumab, Vedolizumab, Ustekinumab, other biologic",
                    "criterion": "prior exposure to Infliximab, Adalimumab, Vedolizumab, Ustekinumab, other biologic",
                    "requirements": [
                        {
                            "requirement_type": "time since last dose",
                            "expected_value": {
                                "operator": ">=",
                                "value": 112,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Evidence of active inflammatory disease despite treatment with at least one conventional therapy",
            "criterions": [
                {
                    "exact_snippets": "Evidence of active inflammatory disease",
                    "criterion": "active inflammatory disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "despite treatment with at least one conventional therapy",
                    "criterion": "treatment with conventional therapy",
                    "requirements": [
                        {
                            "requirement_type": "number of therapies",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "conventional therapy"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. IBD diagnosis for at least 3 months, confirmed by clinical, biochemical, and endoscopic evaluations",
            "criterions": [
                {
                    "exact_snippets": "IBD diagnosis for at least 3 months",
                    "criterion": "IBD diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "confirmed by clinical, biochemical, and endoscopic evaluations",
                    "criterion": "IBD diagnosis confirmation",
                    "requirements": [
                        {
                            "requirement_type": "confirmation_method",
                            "expected_value": [
                                "clinical evaluations",
                                "biochemical evaluations",
                                "endoscopic evaluations"
                            ]
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "9. Implantable electronic devices such as pacemakers, defibrillators, hearing aids, cochlear implants or deep brain stimulators.",
            "criterions": [
                {
                    "exact_snippets": "Implantable electronic devices such as pacemakers, defibrillators, hearing aids, cochlear implants or deep brain stimulators",
                    "criterion": "implantable electronic devices",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "device_type",
                            "expected_value": [
                                "pacemakers",
                                "defibrillators",
                                "hearing aids",
                                "cochlear implants",
                                "deep brain stimulators"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "16. Comorbid disease with high likelihood of requiring corticosteroid use",
            "criterions": [
                {
                    "exact_snippets": "Comorbid disease with high likelihood of requiring corticosteroid use",
                    "criterion": "comorbid disease",
                    "requirements": [
                        {
                            "requirement_type": "likelihood of requiring corticosteroid use",
                            "expected_value": "high"
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Active treatment with antibiotics",
            "criterions": [
                {
                    "exact_snippets": "Active treatment with antibiotics",
                    "criterion": "antibiotic treatment",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        },
        {
            "line": "15. Pregnancy or Lactation",
            "criterions": [
                {
                    "exact_snippets": "Pregnancy",
                    "criterion": "pregnancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Lactation",
                    "criterion": "lactation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "19. Known cardiac condition causing or with potential to cause arrhythmia",
            "criterions": [
                {
                    "exact_snippets": "Known cardiac condition causing or with potential to cause arrhythmia",
                    "criterion": "cardiac condition",
                    "requirements": [
                        {
                            "requirement_type": "potential to cause arrhythmia",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "10. Current tobacco or nicotine user (to limit potential confounding effects of exposure to nicotine)",
            "criterions": [
                {
                    "exact_snippets": "Current tobacco or nicotine user",
                    "criterion": "tobacco or nicotine use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "18. Non-English speaking",
            "criterions": [
                {
                    "exact_snippets": "Non-English speaking",
                    "criterion": "language proficiency",
                    "requirements": [
                        {
                            "requirement_type": "proficiency",
                            "expected_value": "non-English"
                        }
                    ]
                }
            ]
        },
        {
            "line": "14. Any condition which, in the opinion of the investigator, would jeopardize the subject's safety following exposure to a study intervention",
            "criterions": [
                {
                    "exact_snippets": "Any condition which, in the opinion of the investigator, would jeopardize the subject's safety following exposure to a study intervention",
                    "criterion": "any condition jeopardizing subject's safety",
                    "requirements": [
                        {
                            "requirement_type": "investigator opinion",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "jeopardizes safety following exposure to study intervention",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Continuous treatment with an anti-cholinergic medication, including over the counter medications",
            "criterions": [
                {
                    "exact_snippets": "Continuous treatment with an anti-cholinergic medication, including over the counter medications",
                    "criterion": "anti-cholinergic medication treatment",
                    "requirements": [
                        {
                            "requirement_type": "continuity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Presence of intra-abdominal or perirectal abscess",
            "criterions": [
                {
                    "exact_snippets": "Presence of intra-abdominal or perirectal abscess",
                    "criterion": "intra-abdominal abscess",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Presence of intra-abdominal or perirectal abscess",
                    "criterion": "perirectal abscess",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Expectation to increase corticosteroids and/or immunosuppressive treatment",
            "criterions": [
                {
                    "exact_snippets": "Expectation to increase corticosteroids",
                    "criterion": "corticosteroid treatment",
                    "requirements": [
                        {
                            "requirement_type": "expected change",
                            "expected_value": "increase"
                        }
                    ]
                },
                {
                    "exact_snippets": "Expectation to increase ... immunosuppressive treatment",
                    "criterion": "immunosuppressive treatment",
                    "requirements": [
                        {
                            "requirement_type": "expected change",
                            "expected_value": "increase"
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Presence of active intestinal infection or documented infection by stool PCR or culture analysis in the previous 6 weeks",
            "criterions": [
                {
                    "exact_snippets": "Presence of active intestinal infection",
                    "criterion": "active intestinal infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "documented infection by stool PCR or culture analysis in the previous 6 weeks",
                    "criterion": "infection detected by stool PCR or culture analysis",
                    "requirements": [
                        {
                            "requirement_type": "detection_method",
                            "expected_value": [
                                "stool PCR",
                                "culture analysis"
                            ]
                        },
                        {
                            "requirement_type": "time_window",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 6,
                                        "unit": "weeks"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "11. Bowel resection surgery within past 90 days prior to study enrollment and on no conventional IBD therapy, or planned surgery within the course of the study",
            "criterions": [
                {
                    "exact_snippets": "Bowel resection surgery within past 90 days prior to study enrollment",
                    "criterion": "bowel resection surgery",
                    "requirements": [
                        {
                            "requirement_type": "time since surgery",
                            "expected_value": {
                                "operator": "<=",
                                "value": 90,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "on no conventional IBD therapy",
                    "criterion": "conventional IBD therapy",
                    "requirements": [
                        {
                            "requirement_type": "current therapy",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "planned surgery within the course of the study",
                    "criterion": "planned surgery",
                    "requirements": [
                        {
                            "requirement_type": "planned during study",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "13. Participation in any other Investigational drug and/or treatment currently or planned during the length of the study",
            "criterions": [
                {
                    "exact_snippets": "Participation in any other Investigational drug and/or treatment currently or planned during the length of the study",
                    "criterion": "participation in other investigational drug and/or treatment",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": "currently or planned during the length of the study"
                        }
                    ]
                }
            ]
        },
        {
            "line": "12. Any planned surgical procedure requiring general anesthesia within the course of the study",
            "criterions": [
                {
                    "exact_snippets": "Any planned surgical procedure requiring general anesthesia within the course of the study",
                    "criterion": "planned surgical procedure requiring general anesthesia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "within the course of the study"
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Presence of bowel stricture with prestenotic dilatation",
            "criterions": [
                {
                    "exact_snippets": "Presence of bowel stricture",
                    "criterion": "bowel stricture",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "prestenotic dilatation",
                    "criterion": "prestenotic dilatation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Pediatric UC activity Index (PUCAI) score ≥ 65 (severe)",
            "criterions": [
                {
                    "exact_snippets": "Pediatric UC activity Index (PUCAI) score ≥ 65 (severe)",
                    "criterion": "Pediatric UC activity Index (PUCAI) score",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 65,
                                "unit": ""
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "17. Inability to comply with study and follow-up procedures",
            "criterions": [
                {
                    "exact_snippets": "Inability to comply with study and follow-up procedures",
                    "criterion": "ability to comply with study and follow-up procedures",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. weighted Pediatric Crohn Disease Activity Index (wPCDAI) score > 57.5 (severe)",
            "criterions": [
                {
                    "exact_snippets": "weighted Pediatric Crohn Disease Activity Index (wPCDAI) score > 57.5 (severe)",
                    "criterion": "weighted Pediatric Crohn Disease Activity Index (wPCDAI) score",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">",
                                "value": 57.5,
                                "unit": ""
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}